A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK)

See also
Status	Clinical Trial	Phase
Completed	`NCT03662516` - A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects	Phase 1
Completed	`NCT01604980` - Determination of Protein Requirements in Elderly Female Subjects >75 Yrs Old	N/A
Completed	`NCT05738733` - A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03662516 - A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects

Phase 1

Completed

NCT01604980 - Determination of Protein Requirements in Elderly Female Subjects >75 Yrs Old

N/A

Completed

NCT05738733 - A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03608241
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	September 21, 2018
Completion date	November 23, 2018

A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms